Company intelligence / Profile preview

NecstGen

Leiden, South Holland, Netherlandsnecstgen.com ↗

Ownership: Private
Development stage: Commercial

Overview

NecstGen enables academic and industry partners to translate early-stage research into clinical-grade cell and gene therapies by providing GMP-compliant development, manufacturing services, cleanroom rental, and consultancy. It has recently partnered with Galapagos to manufacture decentralized CAR-T products for hematological cancers.

Therapeutic areas: OncologyEndocrinologyRare Diseases
Modalities: Cell therapyGene therapyViral vector-based therapiesStem cell therapyRegenerative medicine therapies
Industry: Contract Manufacturing Organization

Partnerships

Galapagos NV – collaboration on decentralized CAR-T cell therapy manufacturing for hematological malignancies and solid tumors.

Beyond the preview

Go deeper on NecstGen.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on NecstGen.

Explore the full profile